Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000512941 | SCV000608724 | likely pathogenic | not provided | 2017-06-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001366545 | SCV001562851 | uncertain significance | Aortic valve disease 2 | 2020-03-11 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. The current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in SMAD6 cause disease. This variant has not been reported in the literature in individuals with SMAD6-related conditions. ClinVar contains an entry for this variant (Variation ID: 444344). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This sequence change creates a premature translational stop signal (p.Arg42*) in the SMAD6 gene. It is expected to result in an absent or disrupted protein product. |
Gene |
RCV000512941 | SCV002008368 | uncertain significance | not provided | 2021-04-08 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 32499606) |